From my understanding to date, it seems that BTM has had a more straightforward path through FDA than some. On face value the technology is also pretty straightforward for people to understand. That can be a big psychological hurdle for people to overcome with a new product before they start feeling comfortable with the technology.
The bio-compatibility of the BTM matrix is the core product risk in my view and paradoxically its core advantage so I think that as long as there are no doubts around that risk and the trials keep coming up with excellent outcomes I believe the progress will be steady. The long term compatibility and any residual isues will be be something the company will keep a close eye on as well I would think.
PNV will need to invest a fair bit of marketing effort through papers and presentations to doctors to get good market penetration as word of mouth does not cut it. The medical people will want to see lots of evidence then get training with others using the product.
This is where the dollars will need to be spent wisely for best effect and where the experience of the management will tell. Having BARDA feasibility trials certainly will be helpful as PNV can generate a lot of positive marketing collateral from that work. It also helps refine the product application knowledge and provides more data for product indications as well as providing experience to doctors in its application that can be propagated to other medical centres.
If the marketing is good then penetration will flow but it will require persistence.
GLTAH
- Forums
- ASX - By Stock
- PNV
- Polynovo Channel 7
Polynovo Channel 7, page-37
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.58 |
Change
0.020(0.78%) |
Mkt cap ! $1.780B |
Open | High | Low | Value | Volume |
$2.61 | $2.63 | $2.56 | $2.465M | 952.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10700 | $2.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.58 | 24502 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1356 | 2.560 |
3 | 14994 | 2.550 |
5 | 18736 | 2.540 |
2 | 3382 | 2.530 |
2 | 19162 | 2.520 |
Price($) | Vol. | No. |
---|---|---|
2.580 | 1698 | 1 |
2.590 | 2201 | 1 |
2.600 | 2201 | 1 |
2.610 | 2201 | 1 |
2.620 | 2201 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |